{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:46:34Z","timestamp":1779925594048,"version":"3.53.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH108654"],"award-info":[{"award-number":["R01 MH108654"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50 MH080713"],"award-info":[{"award-number":["P50 MH080713"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH101746"],"award-info":[{"award-number":["R21 MH101746"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH101746"],"award-info":[{"award-number":["R21 MH101746"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH101746"],"award-info":[{"award-number":["R21 MH101746"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41386-022-01470-7","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T05:05:09Z","timestamp":1664946309000},"page":"2245-2251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Frontal lobe fALFF measured from resting-state fMRI as a prognostic biomarker in first-episode psychosis"],"prefix":"10.1038","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-338X","authenticated-orcid":false,"given":"Todd","family":"Lencz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Moyett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-1776","authenticated-orcid":false,"given":"Miklos","family":"Argyelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita D.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cholewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-7812","authenticated-orcid":false,"given":"Juan A.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majnu","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Szeszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-4507","authenticated-orcid":false,"given":"Delbert G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"1470_CR1","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Dis Prim. 2015;1:15067.","journal-title":"Nat Rev Dis Prim"},{"key":"1470_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","volume":"6","author":"SG Potkin","year":"2020","unstructured":"Potkin SG, Kane JM, Correll CU, Lindenmayer J-P, Agid O, Marder SR, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6:1.","journal-title":"NPJ Schizophr"},{"key":"1470_CR3","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1017\/S0033291717000435","volume":"47","author":"A Demjaha","year":"2017","unstructured":"Demjaha A, Lappin JM, Stahl D, Patel MX, MacCabe JH, Howes OD, et al. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychological Med. 2017;47:1981\u20139.","journal-title":"Psychological Med"},{"key":"1470_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","volume":"27","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Li C, Huhn M, Rothe P, Krause M, Bighelli I, et al. How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2017;27:835\u201344.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/2045125318781475","volume":"8","author":"PM Haddad","year":"2018","unstructured":"Haddad PM, Correll CU. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses. Ther Adv Psychopharmacol. 2018;8:303\u201318.","journal-title":"Ther Adv Psychopharmacol"},{"key":"1470_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/schbul\/sbv125","volume":"41","author":"DG Robinson","year":"2015","unstructured":"Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang J-P, et al. A randomized comparison of aripiprazole and risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3-month outcomes. Schizophr Bull. 2015;41:1227\u201336.","journal-title":"Schizophr Bull"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1176\/ajp.2006.163.12.2096","volume":"163","author":"DG Robinson","year":"2006","unstructured":"Robinson DG, Woerner MG, Napolitano B, Patel RC, Sevy SM, Gunduz-Bruce H, et al. Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes. Am J Psychiatry. 2006;163:2096\u2013102.","journal-title":"Am J Psychiatry"},{"key":"1470_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/NMD.0000000000000296","volume":"203","author":"M Nordentoft","year":"2015","unstructured":"Nordentoft M, Madsen T, Fedyszyn I. Suicidal behavior and mortality in first-episode psychosis. J Nerv Ment Dis. 2015;203:387\u201392.","journal-title":"J Nerv Ment Dis"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/eip.12697","volume":"13","author":"P Str\u00e5lin","year":"2019","unstructured":"Str\u00e5lin P, Hetta J. Medication, hospitalizations and mortality in 5 years after first-episode psychosis in a Swedish nation-wide cohort. Early Intervention Psychiatry. 2019;13:902\u20137.","journal-title":"Early Intervention Psychiatry"},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852900026213","volume":"12","author":"PF Buckley","year":"2007","unstructured":"Buckley PF, Correll CU, Miller AL. First-episode psychosis: a window of opportunity for best practices. CNS Spectr. 2007;12:1\u201312. discussion 13-14; quiz 15\u201316.","journal-title":"CNS Spectr"},{"key":"1470_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/S0007125000297663","volume":"172","author":"M Birchwood","year":"1998","unstructured":"Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172:53\u201359.","journal-title":"Br J Psychiatry Suppl"},{"key":"1470_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/schbul\/sbv002","volume":"41","author":"G Fond","year":"2015","unstructured":"Fond G, d\u2019Albis M-A, Jamain S, Tamouza R, Arango C, Fleischhacker WW, et al. The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull. 2015;41:559\u2013573.","journal-title":"Schizophr Bull"},{"key":"1470_CR13","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/schbul\/sbv117","volume":"41","author":"AK Malhotra","year":"2015","unstructured":"Malhotra AK. Dissecting the heterogeneity of treatment response in first-episode schizophrenia. Schizophr Bull. 2015;41:1224\u20136.","journal-title":"Schizophr Bull"},{"key":"1470_CR14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/mp.2011.146","volume":"17","author":"AK Malhotra","year":"2012","unstructured":"Malhotra AK, Zhang J-P, Lencz T. Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry. 2012;17:760\u20139.","journal-title":"Mol Psychiatry"},{"key":"1470_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.schres.2019.07.020","volume":"211","author":"NK Chan","year":"2019","unstructured":"Chan NK, Kim J, Shah P, Brown EE, Plitman E, Carravaggio F, et al. Resting-state functional connectivity in treatment response and resistance in schizophrenia: a systematic review. Schizophrenia Res. 2019;211:10\u201320.","journal-title":"Schizophrenia Res"},{"key":"1470_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2017.02.026","volume":"189","author":"TE Mwansisya","year":"2017","unstructured":"Mwansisya TE, Hu A, Li Y, Chen X, Wu G, Huang X, et al. Task and resting-state fMRI studies in first-episode schizophrenia: a systematic review. Schizophrenia Res. 2017;189:9\u201318.","journal-title":"Schizophrenia Res"},{"key":"1470_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrn2201","volume":"8","author":"MD Fox","year":"2007","unstructured":"Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8:700\u201311.","journal-title":"Nat Rev Neurosci"},{"key":"1470_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41591-020-0793-8","volume":"26","author":"A Li","year":"2020","unstructured":"Li A, Zalesky A, Yue W, Howes O, Yan H, Liu Y, et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med. 2020;26:558\u201365.","journal-title":"Nat Med"},{"key":"1470_CR19","doi-asserted-by":"publisher","first-page":"e01211","DOI":"10.1002\/brb3.1211","volume":"9","author":"L-B Cui","year":"2019","unstructured":"Cui L-B, Cai M, Wang X-R, Zhu Y-Q, Wang L-X, Xi Y-B, et al. Prediction of early response to overall treatment for schizophrenia: a functional magnetic resonance imaging study. Brain Behav. 2019;9:e01211.","journal-title":"Brain Behav"},{"key":"1470_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/NDT.S305117","volume":"17","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiang Y, Su W, Xu L, Wei Y, Tang Y, et al. Temporal dynamics in degree centrality of brain functional connectome in first-episode schizophrenia with different short-term treatment responses: a longitudinal study. Neuropsychiatr Dis Treat. 2021;17:1505\u201316.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1470_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1176\/appi.ajp.2015.14121571","volume":"173","author":"DK Sarpal","year":"2016","unstructured":"Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, et al. Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment. Am J Psychiatry. 2016;173:69\u201377.","journal-title":"Am J Psychiatry"},{"key":"1470_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/schbul\/sbz034","volume":"46","author":"G Tarcijonas","year":"2020","unstructured":"Tarcijonas G, Foran W, Haas GL, Luna B, Sarpal DK. Intrinsic connectivity of the globus pallidus: an uncharted marker of functional prognosis in people with first-episode schizophrenia. Schizophr Bull. 2020;46:184\u201392.","journal-title":"Schizophr Bull"},{"key":"1470_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.schres.2019.11.017","volume":"215","author":"S Han","year":"2020","unstructured":"Han S, Becker B, Duan X, Cui Q, Xin F, Zong X, et al. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophrenia Res. 2020;215:89\u201396.","journal-title":"Schizophrenia Res"},{"key":"1470_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41380-018-0106-5","volume":"25","author":"B Cao","year":"2020","unstructured":"Cao B, Cho RY, Chen D, Xiu M, Wang L, Soares JC, et al. Treatment response prediction and individualized identification of first-episode drug-na\u00efve schizophrenia using brain functional connectivity. Mol Psychiatry. 2020;25:906\u201313.","journal-title":"Mol Psychiatry"},{"key":"1470_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ebiom.2019.07.022","volume":"46","author":"H Li","year":"2019","unstructured":"Li H, Guo W, Liu F, Chen J, Su Q, Zhang Z, et al. Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: results from two independent study samples. EBioMedicine. 2019;46:248\u201355.","journal-title":"EBioMedicine"},{"key":"1470_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3389\/fpsyt.2019.00741","volume":"10","author":"R Wu","year":"2019","unstructured":"Wu R, Ou Y, Liu F, Chen J, Li H, Zhao J, et al. Reduced brain activity in the right putamen as an early predictor for treatment response in drug-naive, first-episode schizophrenia. Front Psychiatry. 2019;10:741.","journal-title":"Front Psychiatry"},{"key":"1470_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","volume":"50","author":"S Kapur","year":"2001","unstructured":"Kapur S, Remington G. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry. 2001;50:873\u201383.","journal-title":"Biol Psychiatry"},{"key":"1470_CR28","doi-asserted-by":"publisher","first-page":"107704","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.","journal-title":"Neuropharmacology"},{"key":"1470_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.schres.2019.03.015","volume":"208","author":"L-X Wang","year":"2019","unstructured":"Wang L-X, Guo F, Zhu Y-Q, Wang H-N, Liu W-M, Li C, et al. Effect of second-generation antipsychotics on brain network topology in first-episode schizophrenia: a longitudinal rs-fMRI study. Schizophrenia Res. 2019;208:160\u20136.","journal-title":"Schizophrenia Res"},{"key":"1470_CR30","doi-asserted-by":"publisher","first-page":"737179","DOI":"10.3389\/fpsyt.2021.737179","volume":"12","author":"C Yao","year":"2021","unstructured":"Yao C, Hu N, Cao H, Tang B, Zhang W, Xiao Y, et al. A multimodal fusion analysis of pretreatment anatomical and functional cortical abnormalities in responsive and non-responsive schizophrenia. Front Psychiatry. 2021;12:737179.","journal-title":"Front Psychiatry"},{"key":"1470_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneumeth.2008.04.012","volume":"172","author":"Q-H Zou","year":"2008","unstructured":"Zou Q-H, Zhu C-Z, Yang Y, Zuo X-N, Long X-Y, Cao Q-J, et al. An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods. 2008;172:137\u201341.","journal-title":"J Neurosci Methods"},{"key":"1470_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroimage.2015.03.017","volume":"113","author":"M Aiello","year":"2015","unstructured":"Aiello M, Salvatore E, Cachia A, Pappat\u00e0 S, Cavaliere C, Prinster A, et al. Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: a PET\/MR hybrid scanner study. Neuroimage. 2015;113:111\u201321.","journal-title":"Neuroimage"},{"key":"1470_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/jcbfm.2014.228","volume":"35","author":"AC Nugent","year":"2015","unstructured":"Nugent AC, Martinez A, D\u2019Alfonso A, Zarate CA, Theodore WH. The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABAA-binding potential: a preliminary study in healthy subjects and those with temporal lobe epilepsy. J Cereb Blood Flow Metab. 2015;35:583\u201391.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1470_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fneur.2019.00566","volume":"10","author":"F Jiao","year":"2019","unstructured":"Jiao F, Gao Z, Shi K, Jia X, Wu P, Jiang C, et al. Frequency-dependent relationship between resting-state fMRI and glucose metabolism in the elderly. Front Neurol. 2019;10:566.","journal-title":"Front Neurol"},{"key":"1470_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuroimage.2018.04.048","volume":"176","author":"R Marchitelli","year":"2018","unstructured":"Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, et al. Simultaneous resting-state FDG-PET\/fMRI in Alzheimer disease: relationship between glucose metabolism and intrinsic activity. Neuroimage. 2018;176:246\u201358.","journal-title":"Neuroimage"},{"key":"1470_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/brain.2018.0628","volume":"9","author":"JR Sato","year":"2019","unstructured":"Sato JR, Biazoli CE, Moura LM, Crossley N, Zugman A, Picon FA, et al. Association between fractional amplitude of low-frequency spontaneous fluctuation and degree centrality in children and adolescents. Brain Connect. 2019;9:379\u201387.","journal-title":"Brain Connect"},{"key":"1470_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnhum.2013.00118","volume":"7","author":"X Di","year":"2013","unstructured":"Di X, Kim EH, Huang C-C, Tsai S-J, Lin C-P, Biswal BB. The influence of the amplitude of low-frequency fluctuations on resting-state functional connectivity. Front Hum Neurosci. 2013;7:118.","journal-title":"Front Hum Neurosci"},{"key":"1470_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuroimage.2013.03.004","volume":"76","author":"C-G Yan","year":"2013","unstructured":"Yan C-G, Cheung B, Kelly C, Colcombe S, Craddock RC, Di Martino A, et al. A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics. Neuroimage. 2013;76:183\u2013201.","journal-title":"Neuroimage"},{"key":"1470_CR39","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.neuroimage.2009.09.037","volume":"49","author":"X-N Zuo","year":"2010","unstructured":"Zuo X-N, Di Martino A, Kelly C, Shehzad ZE, Gee DG, Klein DF, et al. The oscillating brain: complex and reliable. NeuroImage. 2010;49:1432\u201345.","journal-title":"NeuroImage"},{"key":"1470_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuroimage.2014.09.038","volume":"103","author":"M K\u00fcblb\u00f6ck","year":"2014","unstructured":"K\u00fcblb\u00f6ck M, Woletz M, H\u00f6flich A, Sladky R, Kranz GS, Hoffmann A, et al. Stability of low-frequency fluctuation amplitudes in prolonged resting-state fMRI. Neuroimage. 2014;103:249\u201357.","journal-title":"Neuroimage"},{"key":"1470_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pscychresns.2011.09.012","volume":"201","author":"JA Turner","year":"2012","unstructured":"Turner JA, Chen H, Mathalon DH, Allen EA, Mayer AR, Abbott CC, et al. Reliability of the amplitude of low-frequency fluctuations in resting state fMRI in chronic schizophrenia. Psychiatry Res. 2012;201:253\u201355.","journal-title":"Psychiatry Res"},{"key":"1470_CR42","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/mp.2012.105","volume":"17","author":"S Kapur","year":"2012","unstructured":"Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012;17:1174\u20139.","journal-title":"Mol Psychiatry"},{"key":"1470_CR43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/archgenpsychiatry.2010.84","volume":"67","author":"S Lui","year":"2010","unstructured":"Lui S, Li T, Deng W, Jiang L, Wu Q, Tang H, et al. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by \u201cresting state\u201d functional magnetic resonance imaging. Arch Gen Psychiatry. 2010;67:783\u201392.","journal-title":"Arch Gen Psychiatry"},{"key":"1470_CR44","first-page":"112","volume":"24","author":"MG Woerner","year":"1988","unstructured":"Woerner MG, Mannuzza S, Kane JM. Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull. 1988;24:112\u20137.","journal-title":"Psychopharmacol Bull"},{"key":"1470_CR45","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1523\/JNEUROSCI.0257-12.2012","volume":"32","author":"T Kahnt","year":"2012","unstructured":"Kahnt T, Chang LJ, Park SQ, Heinzle J, Haynes J-D. Connectivity-based parcellation of the human orbitofrontal cortex. J Neurosci. 2012;32:6240\u201350.","journal-title":"J Neurosci"},{"key":"1470_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01333-7","volume":"11","author":"ET Rolls","year":"2021","unstructured":"Rolls ET. Attractor cortical neurodynamics, schizophrenia, and depression. Transl Psychiatry. 2021;11:215.","journal-title":"Transl Psychiatry"},{"key":"1470_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.neuro.30.051606.094334","volume":"30","author":"JD Wallis","year":"2007","unstructured":"Wallis JD. Orbitofrontal cortex and its contribution to decision-making. Annu Rev Neurosci. 2007;30:31\u201356.","journal-title":"Annu Rev Neurosci"},{"key":"1470_CR48","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1523\/JNEUROSCI.1989-14.2015","volume":"35","author":"VD Costa","year":"2015","unstructured":"Costa VD, Tran VL, Turchi J, Averbeck BB. Reversal learning and dopamine: a bayesian perspective. J Neurosci. 2015;35:2407\u201316.","journal-title":"J Neurosci"},{"key":"1470_CR49","doi-asserted-by":"publisher","first-page":"102852","DOI":"10.1016\/j.nicl.2021.102852","volume":"32","author":"T Itahashi","year":"2021","unstructured":"Itahashi T, Noda Y, Iwata Y, Tarumi R, Tsugawa S, Plitman E, et al. Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia. Neuroimage Clin. 2021;32:102852.","journal-title":"Neuroimage Clin"},{"key":"1470_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2020.07.034","volume":"130","author":"TN Akudjedu","year":"2020","unstructured":"Akudjedu TN, Tronchin G, McInerney S, Scanlon C, Kenney JPM, McFarland J, et al. Progression of neuroanatomical abnormalities after first-episode of psychosis: a 3-year longitudinal sMRI study. J Psychiatr Res. 2020;130:137\u201351.","journal-title":"J Psychiatr Res"},{"key":"1470_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.schres.2015.03.001","volume":"164","author":"L M\u00f8rch-Johnsen","year":"2015","unstructured":"M\u00f8rch-Johnsen L, Nesv\u00e5g R, Faerden A, Haukvik UK, J\u00f8rgensen KN, Lange EH, et al. Brain structure abnormalities in first-episode psychosis patients with persistent apathy. Schizophr Res. 2015;164:59\u201364.","journal-title":"Schizophr Res"},{"key":"1470_CR52","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1523\/JNEUROSCI.4182-14.2015","volume":"35","author":"T Kahnt","year":"2015","unstructured":"Kahnt T, Weber SC, Haker H, Robbins TW, Tobler PN. Dopamine D2-receptor blockade enhances decoding of prefrontal signals in humans. J Neurosci. 2015;35:4104\u201311.","journal-title":"J Neurosci"},{"key":"1470_CR53","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1093\/cercor\/bhr354","volume":"22","author":"DM Cole","year":"2012","unstructured":"Cole DM, Beckmann CF, Searle GE, Plisson C, Tziortzi AC, Nichols TE, et al. Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability. Cereb Cortex. 2012;22:2784\u201393.","journal-title":"Cereb Cortex"},{"key":"1470_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neubiorev.2015.09.016","volume":"59","author":"J Looijestijn","year":"2015","unstructured":"Looijestijn J, Blom JD, Aleman A, Hoek HW, Goekoop R. An integrated network model of psychotic symptoms. Neurosci Biobehav Rev. 2015;59:238\u201350.","journal-title":"Neurosci Biobehav Rev"},{"key":"1470_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1523\/JNEUROSCI.2827-16.2016","volume":"37","author":"T Kahnt","year":"2017","unstructured":"Kahnt T, Tobler PN. Dopamine modulates the functional organization of the orbitofrontal cortex. J Neurosci. 2017;37:1493\u2013504.","journal-title":"J Neurosci"},{"key":"1470_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","volume":"72","author":"DK Sarpal","year":"2015","unstructured":"Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, et al. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry. 2015;72:5\u201313.","journal-title":"JAMA Psychiatry"},{"key":"1470_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41386-021-01100-8","volume":"47","author":"R Cools","year":"2022","unstructured":"Cools R, Arnsten AFT. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine. Neuropsychopharmacology. 2022;47:309\u201328.","journal-title":"Neuropsychopharmacology"},{"key":"1470_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41386-021-01123-1","volume":"47","author":"A Soltani","year":"2022","unstructured":"Soltani A, Koechlin E. Computational models of adaptive behavior and prefrontal cortex. Neuropsychopharmacology. 2022;47:58\u201371.","journal-title":"Neuropsychopharmacology"},{"key":"1470_CR59","volume-title":"Neurochemical modulation of orbitofrontal cortex function. The orbitofrontal cortex","author":"TW Robbins","year":"2006","unstructured":"Robbins TW, Clark L, Clarke H, Roberts AC. Neurochemical modulation of orbitofrontal cortex function. The orbitofrontal cortex. Oxford: Oxford University Press; 2006. 10.1093\/acprof:oso\/9780198565741.003.0016"},{"key":"1470_CR60","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s00213-018-5042-1","volume":"235","author":"B Jalal","year":"2018","unstructured":"Jalal B. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology (Berl). 2018;235:3083\u201391.","journal-title":"Psychopharmacology (Berl)"},{"key":"1470_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.schres.2016.11.008","volume":"183","author":"F Akkus","year":"2017","unstructured":"Akkus F, Treyer V, Ametamey SM, Johayem A, Buck A, Hasler G. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophrenia Res. 2017;183:95\u2013101.","journal-title":"Schizophrenia Res"},{"key":"1470_CR62","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1176\/appi.ajp.2020.20060821","volume":"178","author":"RB Price","year":"2021","unstructured":"Price RB, Gillan CM, Hanlon C, Ferrarelli F, Kim T, Karim HT, et al. Effect of experimental manipulation of the orbitofrontal cortex on short-term markers of compulsive behavior: a theta burst stimulation study. Am J Psychiatry. 2021;178:459\u201368.","journal-title":"Am J Psychiatry"},{"key":"1470_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/schbul\/sbab112","volume":"48","author":"H Cao","year":"2022","unstructured":"Cao H, Wei X, Hu N, Zhang W, Xiao Y, Zeng J, et al. Cerebello-thalamo-cortical hyperconnectivity classifies patients and predicts long-term treatment outcome in first-episode schizophrenia. Schizophr Bull. 2022;48:505\u201313.","journal-title":"Schizophr Bull"},{"key":"1470_CR64","doi-asserted-by":"publisher","first-page":"sgab032","DOI":"10.1093\/schizbullopen\/sgab032","volume":"2","author":"JO Maximo","year":"2021","unstructured":"Maximo JO, Kraguljac NV, Rountree BG, Lahti AC. Structural and functional default mode network connectivity and antipsychotic treatment response in medication-na\u00efve first episode psychosis patients. Schizophr Bull Open. 2021;2:sgab032.","journal-title":"Schizophr Bull Open"},{"key":"1470_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2021.07.038","volume":"236","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiang Y, Collin G, Liu D, Su W, Xu L, et al. The effects of antipsychotics on interactions of dynamic functional connectivity in the triple-network in first episode schizophrenia. Schizophr Res. 2021;236:29\u201337.","journal-title":"Schizophr Res"},{"key":"1470_CR66","doi-asserted-by":"publisher","unstructured":"Liang S, Wang Q, Greenshaw AJ, Li X, Deng W, Ren H, et al. Aberrant triple-network connectivity patterns discriminate biotypes of first-episode medication-naive schizophrenia in two large independent cohorts. Neuropsychopharmacology. 2021;46:1502\u20139. https:\/\/doi.org\/10.1038\/s41386-020-00926-y","DOI":"10.1038\/s41386-020-00926-y"},{"key":"1470_CR67","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1002\/hbm.25020","volume":"41","author":"A Kottaram","year":"2020","unstructured":"Kottaram A, Johnston LA, Tian Y, Ganella EP, Laskaris L, Cocchi L, et al. Predicting individual improvement in schizophrenia symptom severity at 1-year follow-up: comparison of connectomic, structural, and clinical predictors. Hum Brain Mapp. 2020;41:3342\u201357.","journal-title":"Hum Brain Mapp"},{"key":"1470_CR68","doi-asserted-by":"crossref","unstructured":"Berg\u00e9 D, Lesh TA, Smucny J, Carter CS. Improvement in prefrontal thalamic connectivity during the early course of the illness in recent-onset psychosis: a 12-month longitudinal follow-up resting-state fMRI study. Psychol Med. 2020:1\u20139.","DOI":"10.1017\/S0033291720004808"},{"key":"1470_CR69","first-page":"697","volume":"4","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu L, Hu Y, Wu J, Li C, Wang J, et al. Functional connectivity between sensory-motor subnetworks reflects the duration of untreated psychosis and predicts treatment outcome of first-episode drug-na\u00efve schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:697\u2013705.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"1470_CR70","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/schbul\/sbz076","volume":"46","author":"EM Blessing","year":"2020","unstructured":"Blessing EM, Murty VP, Zeng B, Wang J, Davachi L, Goff DC. Anterior hippocampal\u2013cortical functional connectivity distinguishes antipsychotic na\u00efve first-episode psychosis patients from controls and may predict response to second-generation antipsychotic treatment. Schizophrenia Bull. 2020;46:680\u20139.","journal-title":"Schizophrenia Bull"},{"key":"1470_CR71","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/schbul\/sbv228","volume":"42","author":"NV Kraguljac","year":"2016","unstructured":"Kraguljac NV, White DM, Hadley N, Hadley JA, Ver Hoef L, Davis E, et al. Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: a longitudinal resting state functional MRI study. Schizophr Bull. 2016;42:1046\u201355.","journal-title":"Schizophr Bull"},{"key":"1470_CR72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1523\/JNEUROSCI.2310-14.2015","volume":"35","author":"A Anticevic","year":"2015","unstructured":"Anticevic A, Hu X, Xiao Y, Hu J, Li F, Bi F, et al. Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change. J Neurosci. 2015;35:267\u201386.","journal-title":"J Neurosci"},{"key":"1470_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nicl.2015.11.015","volume":"10","author":"NV Kraguljac","year":"2016","unstructured":"Kraguljac NV, White DM, Hadley JA, Visscher K, Knight D, ver Hoef L, et al. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. Neuroimage Clin. 2016;10:146\u201358.","journal-title":"Neuroimage Clin"},{"key":"1470_CR74","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/npp.2013.305","volume":"39","author":"JA Hadley","year":"2014","unstructured":"Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, et al. Ventral tegmental area\/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology. 2014;39:1020\u201330.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01470-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T15:03:09Z","timestamp":1667487789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01470-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":74,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01470-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.25.21261112","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DGR has been a consultant to Acadia, Advocates for Human Potential, Amalyx, American Psychiatric Association, C4 Innovations,\u00a0Costello Medical Consulting, Health Analytics,\u00a0Innovative Science Solutions, Janssen, Lundbeck, Neurocrine, Neuronix, Otsuka, Teva,\u00a0and US World Meds and has received research support from Otsuka. DGR also provides training and consultation about implementing NAVIGATE treatment that can include compensation. AKM has been a consultant to Genomind, InformedDNA, and Janssen. MLB is a consultant for HearMe and Northshore Therapeutics. JAG has served as a consultant to Alkermes. No other authors report competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}